Evidence map›Paper›PMID 27190090›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Incoming human papillomavirus type 16 genome resides in a vesicular compartment throughout mitosis.

Stephen DiGiuseppe, Wioleta Luszczek, Timothy R Keiffer, Malgorzata Bienkowska-Haba, Lucile G M Guion, Martin J Sapp

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. The Rab5 effector Rabankyrin-5 mediates endosomal fusion and trafficking of human papillomavirus during early entry.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Viral interference of nucleocytoplasmic transport.The Journal of biological chemistry · 2025
    Review
  4. Article
  5. bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Stephen DiGiuseppeDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology and Feist-Weiller Cancer Center, LSU Health Shreveport, Shreveport, LA 71130.
Wioleta LuszczekDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology and Feist-Weiller Cancer Center, LSU Health Shreveport, Shreveport, LA 71130.
Timothy R KeifferDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology and Feist-Weiller Cancer Center, LSU Health Shreveport, Shreveport, LA 71130.
Malgorzata Bienkowska-HabaDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology and Feist-Weiller Cancer Center, LSU Health Shreveport, Shreveport, LA 71130.
Lucile G M GuionDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology and Feist-Weiller Cancer Center, LSU Health Shreveport, Shreveport, LA 71130.
Martin J SappDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology and Feist-Weiller Cancer Center, LSU Health Shreveport, Shreveport, LA 71130 msapp1@lsuhsc.edu.
Louisiana State University Health Sciences Center Shreveport · US

Funding

COBRE Center for Molecular and Tumor VirologyP20GM103433 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI O'CALLAGHAN, DENNIS JOHN · 2012 to 2012
$1.9M
Cell surface events of human papillomavirus type 16 and 18 infectionR01AI081809 · NIAID · LOUISIANA STATE UNIV HSC SHREVEPORT · PI SAPP, MARTIN · 2009 to 2013
$1.8M
NIAID NIH HHS R01 AI081809NIGMS NIH HHS P20 GM103433
6 · The paper itself

Abstract

During the entry process, the human papillomavirus (HPV) capsid is trafficked to the trans-Golgi network (TGN), whereupon it enters the nucleus during mitosis. We previously demonstrated that the minor capsid protein L2 assumes a transmembranous conformation in the TGN. Here we provide evidence that the incoming viral genome dissociates from the TGN and associates with microtubules after the onset of mitosis. Deposition onto mitotic chromosomes is L2-mediated. Using differential staining of an incoming viral genome by small molecular dyes in selectively permeabilized cells, nuclease protection, and flotation assays, we found that HPV resides in a membrane-bound vesicle until mitosis is completed and the nuclear envelope has reformed. As a result, expression of the incoming viral genome is delayed. Taken together, these data provide evidence that HPV has evolved a unique strategy for delivering the viral genome to the nucleus of dividing cells. Furthermore, it is unlikely that nuclear vesicles are unique to HPV, and thus we may have uncovered a hitherto unrecognized cellular pathway that may be of interest for future cell biological studies.

Indexed as

Genome, ViralVirionVirus InternalizationCell NucleusCytoplasmic VesiclesEndosomesHeLa CellsHuman papillomavirus 16HumansMitosisPapillomavirus InfectionsProtein Transporttrans-Golgi NetworkdigitoninHPV entrymitosisnuclear vesiclevesicular transport

Identifiers

PMID27190090
PMCPMC4896702
OpenAlexW2401842250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.